This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shimadzu Corporation acquired Gas chromatograph (GC) catalytic microreactor Business from Activated Research Company, LLC. CI
Certain Common Stock of AR advanced technology, Inc. are subject to a Lock-Up Agreement Ending on 19-DEC-2023. CI
MiCAN Technologies Inc. announced that it has received ¥200 million in funding from RealTechJapan LLC., Fujimori Kogyo Co., Ltd., Shimadzu Corporation CI
IMMUNOSENS Co. Ltd. announced that it has received funding from Global Brain Co., Ltd., Shimadzu Corporation CI
AR advanced technology, Inc. has completed an IPO in the amount of ¥924.21 million. CI
Shyld AI and Shimadzu Corporation Team Up with the Goal of Revolutionizing Healthcare with Groundbreaking AI-Powered UV-C Disinfection Technology CI
Jefferies Adjusts Shimadzu's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy MT
Shimadzu Corporation acquired Biomaneo. CI
AR advanced technology, Inc. has filed an IPO. CI
Shimadzu Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Jefferies Adjusts Shimadzu's Price Target to 5,000 Yen From 5,500 Yen, Keeps at Buy MT
New entries in the Asia Investor Portfolio Our Logo
Shimadzu Corp. Shares Rise on Higher First-Half Profit DJ
Shimadzu Corporation completed the acquisition of 34.7% stake in Nissui Pharmaceutical Co., Ltd. for ¥13.3 billion. CI
Shimadzu Corporation made an offer to acquire a 45.9% stake in Nissui Pharmaceutical Co., Ltd. for ¥17.6 billion. CI
Shimadzu Shares Rise Sharply After Fiscal-Year Net Profit Rose 31% DJ
Rakuten Medical, Inc. and Shimadzu Corporation Enrolls First Patient in the U.S. Clinical Trial of Photoimmunotherapy CI
Shimadzu Corporation Revises Earnings Guidance for the Year 2022 CI
Shimadzu Corporation Provides Interim and Full Year Dividend Guidance 2022 CI
Rakuten Medical and Shimadzu Corporation Announce A Joint Development and Commercialization Agreement CI
Shimadzu Corporation Revises Earnings Guidance for the Fiscal Year Ending March 2021 CI
Shimadzu Corporation Plans to Pay Year End Dividend for the Fiscal Year Ending March 2021 CI
Shimadzu Corporation Announces Earnings Results for the Third Quarter of Fiscal Year 2021 CI
Shimadzu and HORIBA to Collaborate on Development and Sales of LC-Raman Analytical and Measuring Instruments CI
Shimadzu Corporation Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2020 CI
Chart Shimadzu Corporation
More charts
Shimadzu Corp is a Japan-based company mainly engaged in the research, development, manufacture, sale and maintenance of scientific and precision equipment. The Company has four segments. Testing and Measuring Instruments segment is engaged in the provision of chromatographic analysis systems, mass spectrometry systems, light analysis systems, thermal analysis systems, bio-related analysis systems, water quality measurement systems and others. Medical Equipment segment is engaged in the provision of X-ray television (TV) systems, angiography systems, X-ray imaging systems and others. Aircraft Equipment segment is engaged in the provision of flight control systems, air management systems, cockpit display systems and others. Industrial Equipment segment is engaged in the provision of turbomolecular pumps and others. The Company is also engaged in the leasing and management of real estate business.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
4,223 JPY
Average target price
5,176 JPY
Spread / Average Target
+22.57%
Consensus
  1. Stock Market
  2. Equities
  3. 7701 Stock
  4. News Shimadzu Corporation
  5. Jefferies Adjusts Shimadzu's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy